# DC Funds, LP: Form 13F holdings

An institutional investment manager in MCLEAN, VA. SEC CIK 1869028.

- Quarter ended: 2026-06-30
- Filed: 2026-08-14
- Reported value: $1.3m
- Positions: 3 (3 lines in the filing's table; lines for the same security and option type are added together here)
- Compared with: the 13F for the quarter ended 2026-03-31
- Filing: https://www.sec.gov/Archives/edgar/data/1869028/000139834426014487/

## Holdings

As filed, largest first. Reported value is what the manager stated at the quarter end (Jun 30, 2026), in US dollars; it is filing data, not a price. Weight is the share of the total reported value.

| Issuer | Class | Reported value | Weight | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | ---: | --- | --- |
| [TSCAN THERAPEUTICS INC (TCRX)](/companies/tcrx.md) | COM | $617.5k | 49.3% | 630,000 |  | Unchanged |
| BARINTHUS BIOTHERAPEUTICS PL | ADS | $423.9k | 33.8% | 642,204 |  | Unchanged |
| [WEREWOLF THERAPEUTICS INC (HOWL)](/companies/howl.md) | COM | $212.0k | 16.9% | 589,102 |  | Unchanged |

Source: SEC EDGAR, Form 13F-HR, accession 0001398344-26-014487. Last ingested by Listed: Oct 22, 2026, 05:26 ET. No prices; not investment advice.